<DOC>
	<DOCNO>NCT02305732</DOCNO>
	<brief_summary>The rationale Treatment Use Investigational Device Exemption ( IDE ) INTERCEPT PCs address current gap platelet transfusion safety select geographic region . The objective provide access INTERCEPT PCs patient might risk transfusion-transmitted infection ( TTI ) due Chikungunya virus ( CHIKV ) Dengue virus ( DENV ) region substantial proportion population infect risk infection pathogen ( Petersen 2014 ) ; risk asymptomatic infection among qualified blood donor recognize ( Stramer 2012 , Adda 2014 ) . The study design prospective , open label , multi-center , observational study evaluate safety efficacy INTERCEPT platelet component .</brief_summary>
	<brief_title>A Prospective , Open Label , Treatment Use Study Patient Safety Following Transfusion INTERCEPT Platelet Components</brief_title>
	<detailed_description>Upon write informed consent , patient transfuse study PCs accord local practice . Each patient support platelet clinically indicate manner consistent local standard care . The study conduct two phase . During pilot phase , patient sign inform consent study data collect follow transfusion conventional PCs . The objective pilot phase evaluate study logistics data collection method . During INTERCEPT Treatment Use phase , patient sign inform consent receive INTERCEPT PCs , provide blood sample , collect study data ( demographic , transfusion data , safety data ) .</detailed_description>
	<mesh_term>Dengue</mesh_term>
	<mesh_term>Chikungunya Fever</mesh_term>
	<criteria>Patients serious disease expect require require transfusion platelet component ( ) Patient population define Investigator institutional review board ( IRB ) . Patient provide write informed consent Exclusion Criteria Documented allergy psoralens Neonatal patient treat phototherapy device emit wavelength le 425 nm due potential erythema result interaction ultraviolet light amotosalen . Pregnant woman third trim pregnancy ( due possibility neonate may need bilirubin light treatment birth ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chikungunya virus</keyword>
	<keyword>CHIKV</keyword>
	<keyword>Dengue virus</keyword>
	<keyword>DENV</keyword>
	<keyword>pathogen inactivation</keyword>
	<keyword>platelet</keyword>
	<keyword>Puerto Rico</keyword>
</DOC>